SOLENO THERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Soleno Therapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Soleno Therapeutics Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 38.4M shares, a 320% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 38.4M +29.2M +320% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 33.3M +25.2M +308% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 31.7M +23.5M +288% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 15.5M +7.31M +89.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 9.14M -111M -92.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 8.17M -112M -93.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 8.16M +2.84M +53.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 8.16M -71.6M -89.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 120M +40.3M +50.6% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 120M +40.4M +50.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 5.32M -74.3M -93.3% Dec 31, 2021 10-K 2023-03-22
Q3 2021 79.8M +213K +0.27% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 79.8M +199K +0.25% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 79.7M +35M +78.4% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 79.6M +35M +78.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 79.6M +47.8M +150% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 79.6M +47.8M +150% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 44.7M +12.9M +40.6% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 44.7M +12.9M +40.6% Dec 31, 2019 10-K 2021-03-03
Q3 2019 31.8M +10.4M +48.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 31.8M +10.4M +48.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 31.8M +12M +60.7% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 31.8M +12.5M +65.1% Dec 31, 2018 10-K 2020-03-04
Q3 2018 21.4M +11.5M +115% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 21.4M -26.2M -55% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 19.8M -27.7M -58.4% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 19.2M +15.9M +473% Dec 31, 2017 10-K 2019-03-20
Q3 2017 9.97M -5.79M -36.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 47.6M +31.8M +202% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 47.5M +32.1M +208% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 3.36M -10.7M -76% Dec 31, 2016 10-K 2018-04-02
Q3 2016 15.8M +3.44M +28% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 15.8M +8.17M +108% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 15.4M +7.95M +107% Mar 31, 2016 10-Q/A 2016-08-09
Q4 2015 14M +7.25M +107% Dec 31, 2015 10-K 2017-03-15
Q3 2015 12.3M +11.8M +2200% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 7.6M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 7.45M Mar 31, 2015 10-Q 2015-05-04
Q4 2014 6.77M +6.23M +1164% Dec 31, 2014 10-K 2016-03-25
Q3 2014 536K Sep 30, 2014 10-Q 2014-12-18
Q4 2013 536K Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.